Evidence map›Paper›PMID 40733213›Full record

ArticleMolecules (Basel, Switzerland)2025

Design and Biological Evaluation of hBest1-Containing Bilayer Nanostructures.

Pavel Bakardzhiev, Teodora Koleva, Kirilka Mladenova, Pavel Videv, Veselina Moskova-Doumanova, Aleksander Forys, Sławomira Pusz, Tonya Andreeva, Svetla Petrova, Stanislav Rangelov and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pavel BakardzhievInstitute of Polymers, Bulgarian Academy of Sciences, Akad. G. Bonchev Str. 103A, 1113 Sofia, Bulgaria.
Teodora KolevaFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.
Kirilka MladenovaFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.
Pavel VidevFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-9428-861X
Veselina Moskova-DoumanovaFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0001-5316-5835
Aleksander ForysCentre of Polymer and Carbon Materials, Polish Academy of Sciences, ul. M. Curie-Skłodowskiej 34, 41-819 Zabrze, Poland.ORCID 0000-0002-6994-868X
Sławomira PuszCentre of Polymer and Carbon Materials, Polish Academy of Sciences, ul. M. Curie-Skłodowskiej 34, 41-819 Zabrze, Poland.
Tonya AndreevaFaculty Life Sciences, Reutlingen University, Alteburgstraße 150, 72762 Reutlingen, Germany.ORCID 0000-0003-4062-6043
Svetla PetrovaFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.
Stanislav RangelovInstitute of Polymers, Bulgarian Academy of Sciences, Akad. G. Bonchev Str. 103A, 1113 Sofia, Bulgaria.
Jordan DoumanovFaculty of Biology, Sofia University "St. Kliment Ohridski", Dragan Tsankov Blvd., 1164 Sofia, Bulgaria.

Funding

Bulgarian Science Fund KP-06-N83/7, 05.12.2024Ministry of Education and Science of Bulgaria DO1-178/2022scientific cooperation agreement between Bulgarian Academy of Sciences and Polish Academy of Sciences IC-PL/11/2024-2025
6 · The paper itself

Abstract

Bestrophinopathies are a group of inherited retinal diseases caused by mutations in the

Indexed as

BestrophinsEye Diseases, HereditaryLipid BilayersNanostructuresRetinal Diseases1,2-DipalmitoylphosphatidylcholineAnimalsCell MembraneCholesterolDogsGenetic TherapyMadin Darby Canine Kidney CellsMutationRecombinant ProteinsRetinal Pigment Epithelium1,2-DipalmitoylphosphatidylcholineBEST1 protein, humanBestrophinsCholesterolLipid BilayersRecombinant Proteinsbilayer nanostructureshBest1MDCK II cells

Identifiers

PMID40733213
PMCPMC12300095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.